EPALEX Corp — Form D/A
EPALEX Corp of MOUNTAIN VIEW, CA, a company, filed a Form D amendment with the SEC on 2020-12-18. The offering totals $20.3M, of which $20.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-12-18
- Form: D/A
- Accession: 0001755010-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.3M
- Amount sold: $20.3M
- Investors: 7
- Date of first sale: 2018-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330183
Issuer
- Name: EPALEX Corp
- CIK: 0001755010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1049 EL MONTE AVENUE, SUITE C 585, MOUNTAIN VIEW, CA, 94040
- Phone: 659-946-3366 X700
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Randall S Murphy | Director | Mountain View, CA |
| Michael S Rogawski | Director | Mountain View, CA |
| Didric Cederholm | Director | New York, NY |
| Jon Saxe | Director | Mountain View, CA |
| Brendan Magrab | Director | Mountain View, CA |
| Brendan Magrab | Executive Officer | Mountain View, CA |
| Randall Murphy | Director | Mountain View, CA |
| Didric Cedarholm | Director | Mountain View, CA |
| Michael Rogawski | Director | Mountain View, CA |
| Jon S Saxe | Director | Austin, TX |
| Matthew S Smith | Director | Mountain View, CA |
| Arthur Franklin Rice | Director | Pleasanton, CA |
| Arthur Franklin Rice | Executive Officer | Pleasanton, CA |
| Steven F Lincoln | Executive Officer | Walnut Creek, CA |
| Michael A Rogawski | Director | Pleasanton, CA |
| Matthew B Smith | Director | Pleasanton, CA |
| Randall B Murphy | Director | Pleasanton, CA |
| Enrique J Carrazana | Director | Pleasanton, CA |
| Matthew J Smith | Director | Pleasanton, CA |
| Michael J Rogawski | Director | Pleasanton, CA |
Other filings by this issuer (5)
More